Tag: peptide receptor radionucllde therapy

CCF Facebook Live Thomas Hope MD Jan 20 2022 002

Dr. Thomas Hope to Be Featured Guest for CCF’s Luncheon with the Experts

January 16, 2022

Thomas Hope, MD, Director of Molecular Therapy in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco, and Chief of Nuclear Medicine at the San Francisco VA Medical Center, will be the featured guest for …

Lu 177

FDA Approves LUTATHERA® for Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors

January 26, 2018

BREAKING NEWS: On January 26, 2018 the US Food and Drug Administration approved LUTATHERA® marking the first time a radioactive drug, or radiopharmaceutical, has been approved for the treatment of gastroenteropancreatic neuroendocrine tumors